121 related articles for article (PubMed ID: 9566858)
1. Vanadyl treatment normalizes submandibular salivary gland insulin-like immunoreactivity in streptozotocin-diabetic rats.
Deville de Périère D; Poucheret P; Egea JC; Gross R; Masiello P; Cros G; Serrano JJ; Ribes G
Horm Metab Res; 1998 Mar; 30(3):150-2. PubMed ID: 9566858
[TBL] [Abstract][Full Text] [Related]
2. Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: persistence of insulin secreting capacities assessed by isolated pancreas studies.
Poucheret P; Gross R; Cadène A; Mantéguetti M; Serrano JJ; Ribes G; Cros G
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):197-204. PubMed ID: 8927039
[TBL] [Abstract][Full Text] [Related]
3. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Cam MC; Pederson RA; Brownsey RW; McNeill JH
Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of immunoreactive insulin-like activity extracted from rat submandibular gland.
Taouis M; Deville de Périère D; Hillaire-Buys D; Derouet M; Gross R; Simon J; Ribes G
Am J Physiol; 1995 Aug; 269(2 Pt 1):E277-82. PubMed ID: 7653545
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
6. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126
[TBL] [Abstract][Full Text] [Related]
7. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
Dehghani GA; Ahmadi S; Omrani GR
Indian J Med Res; 1997 Nov; 106():481-5. PubMed ID: 9415745
[TBL] [Abstract][Full Text] [Related]
8. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; McNeill JH
Pharmacol Toxicol; 1994 Feb; 74(2):101-9. PubMed ID: 8190697
[TBL] [Abstract][Full Text] [Related]
9. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Li H; Wei Q
IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
[TBL] [Abstract][Full Text] [Related]
10. Effect of insulin-mimetic vanadyl sulfate on cytochrome P450 2E1-dependent p-nitrophenol hydroxylation in the liver microsomes of streptozotocin-induced type 1 diabetic rats.
Kataoka S; Yasui H; Hiromura M; Sakurai H
Life Sci; 2005 Oct; 77(22):2814-29. PubMed ID: 15964029
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
12. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
Ahmed El-Shazly S; Ahmed MM; Ibrahim ZS; Refat MS
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):227-39. PubMed ID: 25816395
[TBL] [Abstract][Full Text] [Related]
14. Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.
Anand-Srivastava MB; McNeill JH; Yang XP
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):113-9. PubMed ID: 8927025
[TBL] [Abstract][Full Text] [Related]
15. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R; Giridhar R; Yadav MR
J Trace Elem Med Biol; 2005; 18(3):211-7. PubMed ID: 15966569
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of vanadyl sulfate on skin injury in streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Hum Exp Toxicol; 2013 Nov; 32(11):1206-12. PubMed ID: 24281993
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
18. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
Liu IM; Chi TC; Cheng JT
Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
[TBL] [Abstract][Full Text] [Related]
19. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
[TBL] [Abstract][Full Text] [Related]
20. Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Goc A; Turyna B; Kordowiak AM
Pol J Pathol; 2004; 55(1):25-32. PubMed ID: 15195703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]